AstraZeneca: all 4,196 studies
Page 32 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069CompletedNCT01100047Phase 1
- Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With SimvastatinCompletedNCT01096940Phase 1
- A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese SubjectsTerminatedNCT01096563Phase 1
- Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose TissueCompletedNCT01096004Phase 1
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes MellitusCompletedNCT01095991Phase 1
- A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose AspirinCompletedNCT01094483Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe PsoriasisCompletedNCT01094093Phase 1
- A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese SubjectsCompletedNCT01093040Phase 1
- A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting ConditionsCompletedNCT01092299Phase 1
- Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043WithdrawnNCT01086813Phase 1
- Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsCompletedNCT01086319
- Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentCompletedNCT01086306
- Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsCompletedNCT01086293
- Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic TreatmentsCompletedNCT01086280
- Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic PatientCompletedNCT01085474
- Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male VolunteersCompletedNCT01085123Phase 1
- Economic Evaluation of Heart Failure Management in Colombian ClinicsCompletedNCT01084564
- This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral DoseCompletedNCT01083238Phase 1
- To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656CompletedNCT01083212Phase 1
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes MellitusCompletedNCT01082120Phase 1
- Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment AdherenceCompletedNCT01081509
- Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)CompletedNCT01081496
- Evaluation of the Frequency of Limitation of Activity in Patients With Persistent AsthmaCompletedNCT01078688
- Study of Undertreatment of Patients With Dyslipidemia in BulgariaCompletedNCT01075594
- Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the KneeTerminatedNCT01072591Phase 1
- A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood GlucoseCompletedNCT01072578Phase 1
- To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus PatientsCompletedNCT01069926Phase 1
- Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)CompletedNCT01069835
- A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood LevelsCompletedNCT01069822Phase 1
- Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy SubjectsTerminatedNCT01068756Phase 1
- A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01068184Phase 1
- A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 DaysCompletedNCT01064388Phase 1
- Study of the Clinical Management of Bipolar DiseaseCompletedNCT01062607
- An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET StudyCompletedNCT01061086
- Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male VolunteersCompletedNCT01058447Phase 1
- Statin Therapy Results in the Real World Practice in the Czech RepublicCompletedNCT01055977
- A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate TabletsCompletedNCT01055691Phase 1
- Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus PatientsCompletedNCT01055652Phase 1
- Evaluation of Target Organs Damage in Hypertensive PatientsCompletedNCT01055353
- A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy VolunteersCompletedNCT01051505Phase 1
- Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take StatinsCompletedNCT01047176
- Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female SubjectsCompletedNCT01046630Phase 1
- A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687CompletedNCT01046357Phase 1
- A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of CognitionCompletedNCT01044342Phase 1
- Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active ControlWithdrawnNCT01043601Phase 2
- 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01039701Phase 2
- Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in FranceCompletedNCT01039402
- Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy VolunteersCompletedNCT01037725Phase 1
- AZD5423 Multiple Ascending Dose StudyCompletedNCT01037504Phase 1
- AZD9668 Relative BioavailabilityCompletedNCT01035411Phase 1
- AZD9668 Relative BioavailabilityCompletedNCT01034982Phase 1
- Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf StatesCompletedNCT01031277
- This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy SubjectsCompletedNCT01030224Phase 1
- Management of Index Episode in Patients With Bipolar Disorder Treated by Seroquel XRCompletedNCT01029145
- Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionCompletedNCT01028196
- AZD Single Ascending Dose Study In Healthy Japanese SubjectsCompletedNCT01028040Phase 1
- Centralized Pan-South African Survey on the Undertreatment of HypercholesterolaemiaCompletedNCT01027624
- This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral DosesTerminatedNCT01027234Phase 1
- Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen AgentCompletedNCT01025479
- Centralized Pan-Middle East Survey on the Undertreatment of HypercholesterolemiaCompletedNCT01025388
- The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With DonepezilCompletedNCT01024660Early Phase 1
- Observational Study To Evaluate Statins Patterns Of Use In SpainWithdrawnNCT01023503
- Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese SubjectCompletedNCT01021189Phase 1
- Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal SymptomsCompletedNCT01020890
- PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated PatientsCompletedNCT01020604
- An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)CompletedNCT01019161Phase 1
- A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary DiseaseTerminatedNCT01016951Phase 1
- Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken SeparatelyTerminatedNCT01015729Phase 1
- A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care SettingCompletedNCT01013922
- Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.CompletedNCT01012375Phase 2
- Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male SubjectsTerminatedNCT01007929Phase 1
- Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01007734
- Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.CompletedNCT01003158Phase 1
- Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted StateCompletedNCT01002807Phase 1
- Allopurinol Combination StudyCompletedNCT01001338Phase 2
- Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelWithdrawnNCT01000896Phase 1
- A Study on the Long Term Survivals in an Expand Access Program (EAP) of IressaCompletedNCT01000740Phase 4
- A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic PatientsCompletedNCT00999895
- Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer PatientsCompletedNCT00999882Phase 1
- Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in ThailandCompletedNCT00999063
- Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken SeparatelyCompletedNCT00998075Phase 1
- Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in SpainCompletedNCT00998062
- 10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesCompletedNCT00997945Phase 1
- A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy VolunteersCompletedNCT00997308Phase 1
- Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or mCompletedNCT00997230
- Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and SulfonylureaCompletedNCT00995787Phase 1
- Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn AloneCompletedNCT00992381Phase 1
- To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid BurdenCompletedNCT00991419Phase 2
- Seroquel XR in Schizophrenia Relapse PreventionCompletedNCT00990626
- The Effects AZD8529 on Cognition and Negative Symptoms in SchizophrenicsCompletedNCT00986531Phase 1
- A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma SymptomsCompletedNCT00986219
- The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy VolunteersCompletedNCT00985933Early Phase 1
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043CompletedNCT00984880Phase 1
- Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in CroatiaCompletedNCT00984529
- Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male SubjectsCompletedNCT00984477Phase 1
- Epidemiology of Schizophrenia in BulgariaCompletedNCT00984373
- Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal ImpairmentTerminatedNCT00984113Phase 1
- An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature InfantsCompletedNCT00983606
- A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid MalignanciesCompletedNCT00981721Phase 1
- Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in CroatiaCompletedNCT00981123